SVRA
Savara Inc
$6.21
+0.01 (+0.16%)
At close · Jul 7
Market Cap
$1.27B
Shares
204,927,212
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$6.21
Open$6.23
Day$6.13–6.48
52W$2.14–7.01
Avg vol 30d1.7M
Short int31.4M · 15.3% float · 19.3d
Short vol68%
Last earningsAug 6, 2020
DataJan 2020–Jul 2026
Filing10-Q · May 12
Equibles Rating
blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Neutral
Fundamentals
Weak
Quant / Vol
Very High
Market backdrop
VIX 16.9 · calm
Equity put/call 0.86
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+19%
above
Price vs 50-day avg
+16%
above
RSI (14)
69
neutral
MACD trend
Positive
52-week position
84%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+22%
trailing
6-month return
+8%
trailing
YTD return
+3%
this year
Relative strength
0%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
1 of 185 funds reported for Jun 30 · net +273 sh shares
Insider flow
Distributing
Net -$2.2M over 90 days · 100% sells
Short interest
Rising
15.30% of float · ▲ +3.9% MoM · 19.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
185 holders — near 3-yr high, broad support
Squeeze score
90
high risk · 0–100
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
−10%
Y/Y
Free cash flow
$-101.1M
Balance sheet
$3.3M
net cash
Quant / Vol
risk profile
Volatility
55%
annualized · 1-yr
Max drawdown
−32%
past year
ATR
4.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 12, 2026
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+19%
Bullish
Price vs 50-day avg
+16%
Bullish
RSI (14)
69
Neutral
MACD trend
Positive
Bullish
52-week position
84%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $5 › 200d $5 — 50d above 200d
Institutional flow
Accumulating
1 of 185 funds reported for Jun 30 · net +273 sh shares
Insider flow
Distributing
Net -$2.2M over 90 days · 100% sells
Short interest
Rising
15.30% of float · ▲ +3.9% MoM · 19.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
185 holders — near 3-yr high, broad support
Price context
position in its 52-week range
52-wk low $2
Now $6 · 84%
52-wk high $7
vs 200-day avg +19%
vs 50-day avg +16%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SVRA
this stock
Savara Inc
|
$1.27B | +3.0% | -100.0% | — | 15.3% |
|
ONC
BeOne Medicines Ltd.
|
$446.53B | +1.7% | +22179.2% | 908.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$126.50B | +9.9% | +46.2% | 31.0 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$70.90B | -12.3% | +20.8% | 16.5 | 3.2% |
|
ARGX
Argenx SE
|
$57.20B | +8.8% | — | — | 2.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SVRA | +3.8% | +22.0% | +7.6% | +0.8% | +3.0% |
| SPY | +0.9% | +1.4% | +7.6% | +0.1% | +9.7% |
| vs SPY | +2.9% | +20.6% | +0.1% | +0.7% | -6.7% |